Involvement of the opioid system in the central antisecretory action of alpha-2 adrenoceptor agonists in rat

J Physiol Paris. 2001 Jan-Dec;95(1-6):209-14. doi: 10.1016/s0928-4257(01)00027-4.

Abstract

The aim of the present study was to analyse the role of the central alpha-2 adrenoceptors in the regulation of gastric acid secretion in pylorus ligated rats. It was found that the intracerebroventricularly (icv.) injected presynaptic alpha-2 adrenoceptor agonist clonidine and the alpha-2A adrenoceptor subtype selective stimulant oxymetazoline exerted a dose dependent inhibition on gastric acid secretion. The antisecretory ED(50) values for clonidine and oxymetazoline were 20 and 7.5 nmol/rat icv., respectively. The antisecretory effect of these compounds was antagonised by the presynaptic adrenoceptor antagonist yohimbine (50 nmol/rat icv.) indicating that the action is mediated through central presynaptic alpha-2 adrenoceptors. Moreover, naloxone (50 nmol/rat icv.)--non-selective opioid antagonist--and naltrindole (0.5 nmol/rat icv.)--delta-opioid receptor selective antagonist--also decreased the antisecretory effect of clonidine and oxymetazoline suggesting that the endogenous opioid system is likely to be involved in the central antisecretory action of alpha-2 adrenoceptor stimulants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology*
  • Adrenergic alpha-Antagonists / pharmacology
  • Animals
  • Brain / drug effects*
  • Brain / physiology*
  • Clonidine / pharmacology
  • Endorphins / physiology*
  • Injections, Intraventricular
  • Naloxone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Oxymetazoline / pharmacology
  • Rats
  • Rats, Wistar
  • Yohimbine / pharmacology

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic alpha-Antagonists
  • Endorphins
  • Narcotic Antagonists
  • Yohimbine
  • Naloxone
  • Oxymetazoline
  • Clonidine